Bank of New York Mellon
VIE

Bank of New York Mellon’s Viela Bio, Inc. Common Stock VIE Stock Holding History

Bank of New York Mellon’s Portfolio VIE Stock Details VIE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-66,566
Closed -$2.39M – 4390
2020
Q4 		$2.39M Buy
66,566
+2,253
+4% +$78.9K ﹤0.01% 2739
2020
Q3 		$1.81M Buy
64,313
+1,269
+2% +$44.9K ﹤0.01% 2725
2020
Q2 		$2.73M Buy
63,044
+42,871
+213% +$1.94M ﹤0.01% 2503
2020
Q1 		$767K Buy
20,173
+6,159
+44% +$240K ﹤0.01% 3151
2019
Q4 		$380K Buy
+14,014
New +$353K ﹤0.01% 3715

Bank of New York Mellon's VIE Position: Q1 2021 in Review

Bank of New York Mellon sold out of Viela Bio, Inc. Common Stock (VIE) in Q1 2021, closing a stake of 66,566 shares — an estimated $2.39M sold.

Bank of New York Mellon first reported a position in VIE in Q4 2019 and held it in 5 quarters. The position peaked at $2.73M in Q2 2020. 0 funds tracked by Wall St. Rank hold VIE as of Q1 2021.

  • Bank of New York Mellon reported no remaining Viela Bio, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Bank of New York Mellon sold 66,566 Viela Bio, Inc. Common Stock shares in Q1 2021, an estimated $2.39M.
  • Bank of New York Mellon first reported a position in Viela Bio, Inc. Common Stock in Q4 2019 and held it in 5 quarters.
  • Bank of New York Mellon's Viela Bio, Inc. Common Stock position peaked at $2.73M in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Viela Bio, Inc. Common Stock as of Q1 2021.

Based on Bank of New York Mellon's 13F filing for Q1 2021, filed 13 May 2021.